Search

Search Constraints

You searched for: Author/Creator Bafutto, Mauro

Search Results

1. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

2. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

6. P-112 Evaluation of Vitamin D Supplementation in Moderate to Severe Crohn's Disease Patients Using Anti-TNF: Replacement or Immunomodulation?. (February 2017)

7. P065 Efficacy and Safety of Ustekinumab in Patients With Crohn's disease: Data From a Real World Study in Brazil. (December 2019)

8. Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study. Issue 4 (1st August 2016)

9. Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study. Issue 4 (August 2016)

10. Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study. Issue 7 (26th October 2021)